Nasdaq

20 stories about Nasdaq
default image

Warburg Pincus Proceeds with Tender Offer for Email Protection Company Cyren

22.11.17|Lilach Baumer
The private equity firm currently holds a 21.3% in Nasdaq-listed Cyren, after buying around 10 million shares earlier this month
מלאנוקס פארק התעשייה תל חי

Starboard Acquires 10.7% Stake in Mellanox

21.11.17|Golan Hazani
The activist investor believes Mellanox must boost its revenue with increased spending on research and development
rewalk רובוטיקה שלד חיצוני

Robotic Exoskeleton Company ReWalk Robotics Aims to Raise $7.2 Million

20.11.17|Lilach Baumer
The company develops a battery-powered, wearable walking aid device for people with spinal cord injuries
דרור חרץ מנכ"ל VBL

VBL Therapeutics Aims to Raise $18.75 Million in Public Offering

20.11.17|Lilach Baumer
The cancer treatment company announced an offering of 2.5 million shares last week
תרופות  טבע גלולות תרופה

Entera Bio Files for Nasdaq IPO

12.11.17|Lilach Baumer
The clinical stage company develops treatments mostly for osteoporosis and bone disorders
בניין הבורסה של פרנקפורט

Frankfurt Stock Exchange Eyes Israel-Based Startups

09.11.17|Meir Orbach
The exchange's small and medium-sized enterprises segment sent representatives to Israel in search of startups that want a European IPO
default image

RedHill's Public Offering Spooks Investors, Sends Stock Down

09.11.17|Dror Reich
The Nasdaq-listed biopharmaceutical company priced its shares at $5.5 per American Depositary Share, a third of its 2015 public offering price, and dropped nearly 30% by Wednesday market close
קובי אלכסנדר איש עסקים לשעבר מנכל קומברס

Convicted Comverse CEO Kobi Alexander Asks to Serve Prison Sentence in Israel

09.11.17|Moshe Gorali, Tomer Ganon, and Tamar Tunik
Mr. Alexander, who fled to Namibia to avoid fraud charges in a 2006 backdating stock options scandal, is now serving time in the U.S.
רכבת ישראל תחנת חדרה

Train Safety Company Rail Vision Considers Nasdaq IPO

09.11.17|Golan Hazani
The company announced it is examining registration on Nasdaq, confirming an earlier Calcalist report
default image

Warburg Pincus Buys Stake in Email Protection Company Cyren

07.11.17|Dror Reich
The private equity acquired a 21.3% stake in Nasdaq-listed Cyren for $19.6 million and plans to increase ownership by buying up to 75% of the company’s shares
קטרינה לייק סטיטצ' פיקס

How Much is Stitch Fix Worth?

02.11.17|Assaf Gilad
A case study valuating pre-IPO companies
יפעת אורון מנכלית לאומיטק

Nasdaq to Launch a Program Supporting Israeli Growth Companies

01.11.17|Meir Orbach
The program will be jointly managed by Israel's second largest bank, Leumi
גיל שויד מנכ"ל צ'ק פוינט הוויעידה המוטסת

Check Point’s Stock Falls in After Hours Trading

01.11.17|Dror Reich
The cybersecurity company’s profit forecast for the fourth quarter disappoints analysts
רון יקותיאל מייסד מנכל קולטורה הוועידה המוטסת סן פרנסיסקו

Video Company Kaltura on Path for U.S. IPO

01.11.17|Golan Hazani
Kaltura raised $50 million in 2016 from Goldman Sachs at an undisclosed valuation. In May a veteran chief financial officer who led past U.S. IPO joined the company
מנכ"ל פורסקאוט מייקל דסיזאר

Private Investment Terms Dampen Forescout’s Successful IPO

29.10.17|Lilach Baumer
On Friday, Forescout raised $116 million on its Nasdaq debut, selling 5.3 million shares at $22 per share
מנכ"ל פורסקאוט מייקל דסיזאר

ForeScout Updates Prospectus, Targets a $942 Million Valuation for IPO

19.10.17|Dror Reich
The information security company aims to raise $96-$105.6 million in a Nasdaq IPO
default image

Israel’s Flagship Company Stayed its Course

16.10.17|Dror Reich
The share price of veteran cybersecurity company Check Point reached a record-breaking $120 over the weekend
מנכ"ל פורסקאוט מייקל דסיזאר

Forescout Files For $100 Million Nasdaq IPO

04.10.17|Dror Reich
Underwriters for the intended initial public offering are Morgan Stanley and J.P. Morgan
default image

Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO

31.08.17|Dror Reich
The clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology
default image

Anti-Acne Drug Developer Plans Nasdaq IPO

15.08.17|Golan Hazani
Sol-Gel approached potential underwriters. It aims to go public before the end of the year